The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2016

Filed:

May. 17, 2012
Applicants:

Jae Wha Kim, Daejeon, KR;

Kyung Seop Ahn, Daejeon, KR;

Ho Bum Kang, Daejeon, KR;

Sei Ryang OH, Daejeon, KR;

Jae Jong Go, Gyeonggi-do, KR;

Joo Heon Kim, Daejeon, KR;

Jang MI Sun, Daejeon, KR;

Jae Sung Song, Daejeon, KR;

Hyun Woo OH, Daejeon, KR;

Da Jung Ji, Daejeon, KR;

Inventors:

Jae Wha Kim, Daejeon, KR;

Kyung Seop Ahn, Daejeon, KR;

Ho Bum Kang, Daejeon, KR;

Sei Ryang Oh, Daejeon, KR;

Jae Jong Go, Gyeonggi-do, KR;

Joo Heon Kim, Daejeon, KR;

Jang Mi Sun, Daejeon, KR;

Jae Sung Song, Daejeon, KR;

Hyun Woo Oh, Daejeon, KR;

Da Jung Ji, Daejeon, KR;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 36/83 (2006.01); A61K 36/185 (2006.01); C07D 319/06 (2006.01); C07D 493/08 (2006.01); A61K 31/357 (2006.01); A61K 47/26 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A23L 1/30 (2006.01); A23L 2/52 (2006.01); A23L 1/10 (2006.01);
U.S. Cl.
CPC ...
C07D 493/08 (2013.01); A23L 1/1041 (2013.01); A23L 1/3002 (2013.01); A23L 2/52 (2013.01); A61K 9/0019 (2013.01); A61K 9/0095 (2013.01); A61K 9/2018 (2013.01); A61K 9/4858 (2013.01); A61K 31/357 (2013.01); A61K 36/83 (2013.01); A61K 47/26 (2013.01); A61K 2236/00 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition for the prevention or treatment of atopy comprising the extract of, the fraction thereof, of the compound isolated from the same as an active ingredient. More precisely, the extract of, the fraction thereof, or the compound isolated from the same, genekwadapnin or yuanhuacine, of the present invention can increase the secretion of cytokine in Th1 immune cells and suppress atopy in the atopy mouse model, so that the extract of, the fraction thereof, or the compound isolated from the same of the present invention can be effectively used for the prevention or treatment of atopy.


Find Patent Forward Citations

Loading…